Brandstetter R D, Gotz V P, Mar D D
South Med J. 1981 Jun;74(6):713-5. doi: 10.1097/00007611-198106000-00021.
We studied 77 patients suffering acute asthma to identify those who needed hospitalization. Patients randomly received various doses of subcutaneous epinephrine. Peak expiratory flow rate (PEFR) was measured initially and at ten and 20 minutes after epinephrine administration. If adequate response was not noted from three doses of epinephrine, aminophylline and later hydrocortisone were given. Patients were admitted to the hospital if they did not improve or required emergency room treatment for four hours. Thirty-five percent (13/37) of the patients with an initial PEFR of less than or equal to 100 liters/min required hospital admission, whereas only 8% (3/40) with an initial PEFR of greater than 100 liters/min required hospitalization (P less than .01). Analysis of patients in the group at high risk also revealed significant differences between hospitalized and nonhospitalized patients in PEFR. Asthmatics with significant airway obstruction (initial PEFR, less than or equal to 100 liters/min) who do not show prompt improvement after optimal epinephrine therapy should be closely observed and considered candidates for hospital admission.
我们研究了77例急性哮喘患者,以确定那些需要住院治疗的患者。患者随机接受不同剂量的皮下注射肾上腺素。在注射肾上腺素前、注射后10分钟和20分钟测量呼气峰值流速(PEFR)。如果三剂肾上腺素未观察到足够的反应,则给予氨茶碱,随后给予氢化可的松。如果患者在4小时内没有改善或需要急诊室治疗,则收入院。初始PEFR小于或等于100升/分钟的患者中有35%(13/37)需要住院,而初始PEFR大于100升/分钟的患者中只有8%(3/40)需要住院(P<0.01)。对高危组患者的分析还显示,住院患者和非住院患者在PEFR方面存在显著差异。气道严重阻塞(初始PEFR小于或等于100升/分钟)的哮喘患者在最佳肾上腺素治疗后未迅速改善,应密切观察并考虑作为住院候选对象。